Clerio Vision, Inc.
Laser-based vision treatment platform using proprietary LIRIC technology
New patent ·
- Sector
- Medtech
- Headquarters
- ROCHESTER, NY
- Founded
- 2014
- Latest Form D
- $5M, Dec 2020
- Total capital
- $27.2M
- Federal grants
- $1.5M
- 2 awards · 2015–2017
- Rank in peer group#236 of 477
- Private capital raised
- $25.7M
- 5 Form D · last Dec 2020
- 70 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 9
- 31 pending · first 2022
- Rank in peer group#29 of 477
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 5th filing$5M
- Private capital raisedForm D · SEC · 4th filing$11.9M
- Federal grantNSF · Phase II · STTR Phase II: Refractive correction using non-invasive laser-induced refractive index change$1.3M
- Private capital raisedForm D · SEC · 3rd filing$3.6M
- Private capital raisedForm D · SEC · 2nd filing$3.2M
- Federal grantNSF · Phase I · STTR Phase I: Refractive correction using non-invasive laser-induced refractive index change$270K
- Private capital raisedForm D · SEC · 1st filing$2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 477 peers
Line = medianMedtech · Device
- Federal grants#236 · top 49%
- Granted patents#29 · top 6%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Alexandra LatypovaExecutive Officer, Director, PromoterNamed in SEC Form D filings
- Alex ZapesochnyExecutive Officer, Director, PromoterNamed in SEC Form D filings
- Arunas ChesonisDirectorNamed in SEC Form D filings
- Brian ModelDirectorNamed in SEC Form D filings
- David WilliamsDirectorNamed in SEC Form D filings
- J. Mikael TottermanExecutive Officer, PromoterNamed in SEC Form D filings
Show all 7 people
- Robert CochraneDirectorNamed in SEC Form D filings
What it has protected
USPTO · 9 granted of 40- New patentLIRIC Calibration Based on Multiphoton ExcitationUSPTOUS 12,766,037
- GrantedEye ScopesUSPTOUS 12,721,518
- PendingContact Lenses With Image Quality Enhancing Annular ZoneUSPTOApplication 19404812
Show all 40 patent records
- LIRIC Calibration Based on Multiphoton ExcitationOct 20, 2026 · US 12,766,037Granted
- Eye ScopesSep 1, 2026 · US 12,721,518Granted
- Contact Lenses With Image Quality Enhancing Annular ZoneMar 26, 2026 · Application 19404812Pending
- Myopia Control TreatmentsJan 8, 2026 · Application 19327360Pending
- Subsurface Optical Structure With Enhanced Distribution of Refractive Index ValuesOct 21, 2025 · US 12,449,675Granted
- Myopia Control TreatmentsOct 14, 2025 · US 12,443,053Granted
- Methods and Devices for Chromatic Aberration CorrectionMay 15, 2025 · Application 19019984Pending
- Myopia Progression TreatmentMay 13, 2025 · US 12,298,600Granted
- Optimized Multifocal Wavefronts for Presbyopia CorrectionDec 24, 2024 · US 12,174,459Granted
- LIRIC Diffractive Deep Neural NetworkSep 19, 2024 · Application 18604226Pending
- Longitudinal Chromatic Aberration Manipulation for Myopia ControlAug 15, 2024 · Application 18440488Pending
- Eye ScopesFeb 1, 2024 · Application 18355567Pending
- Coordinated Scanning and Power Control of Laser for Forming Structures in Ophthalmic LensesJan 11, 2024 · Application 18472885Pending
- LIRIC Calibration Based on Multiphoton ExcitationOct 19, 2023 · Application 18212833Pending
- Optimized Multifocal Wavefronts For Presbyopia CorrectionSep 5, 2023 · US 11,747,650Granted
- Myopia Progression TreatmentJul 4, 2023 · US 11,693,257Granted
- Vision Correction With Laser Refractive Index ChangesJun 28, 2022 · US 11,369,515Granted
- Methods and Systems for Determining Wavefronts for Forming Optical Structures in Ophthalmic LensesDec 9, 2021 · Application 17339713Pending
- Myopia Control Contact Lenses With Subsurface Defocus ElementsApplication 63466137Pending
- Contact Lenses With Image Quality Enhancing Annular ZoneApplication 63470483Pending
- Myopia Control TreatmentsApplication PCTUS2023015295Pending
- LIRIC Diffractive Deep Neural NetworkApplication 63451870Pending
- Longitudinal Chromatic Aberration Manipulation for Myopia ControlApplication 63514471Pending
- Longitudinal Chromatic Aberration Manipulation for Myopia ControlApplication 63445464Pending
- Myopia Control TreatmentsApplication 63397128Pending
- Methods And Devices For Chromatic Aberration CorrectionApplication PCTUS2023028115Pending
- Eye ScopesApplication 63392684Pending
- Methods and Devices for Chromatic Aberration CorrectionApplication 63390700Pending
- Myopia Control TreatmentsApplication 63321447Pending
- Coordinated Scanning And Power Control Of Laser For Forming Structures In Ophthalmic LensesApplication PCTUS2022020549Pending
- Liric Calibration Based On Multiphoton ExcitationApplication PCTUS2021064147Pending
- Subsurface Optical Structure With Enhanced Distribution Of Refractive Index ValuesApplication PCTUS2021046564Pending
- Optimized Multifocal Wavefronts For Presbyopia CorrectionApplication PCTUS2021040697Pending
- Longitudinal Chromatic Aberration Manipulation For Myopia ControlApplication PCTUS2024015583Pending
- Methods And Systems For Determining Wavefronts For Forming Optical Structures In Ophthalmic LensesApplication PCTUS2021035994Pending
- Chromatic Aberration Manipulation in the Peripheral Retina for Myopia ControlApplication 63562906Pending
- Coordinated Scanning and Power Control of Laser for Forming Structures in Ophthalmic LensesApplication 63164752Pending
- LIRIC Calibration Based on Multiphoton ExcitationApplication 63129023Pending
- Subsurface Optical Structure With Enhanced Distribution of Refractive Index ValuesApplication 63069943Pending
- Myopia Control Contact Lenses With Subsurface Defocus And/or Scatter-inducing ElementsApplication PCTUS2024028531Pending
Related companies, and why
- Instapath BiopticsSimilar federal contract value in Medtech · null in contracts
- Avalon Med Spa, LLCSimilar federal contract value in Medtech · null in contracts
- Biothea Pharma, Inc.Similar federal contract value in Medtech · null in contracts
- Clear Advantage Collar, Inc.Similar federal contract value in Medtech · null in contracts
- Obstetrx, Inc.Similar federal contract value in Medtech · null in contracts
- One Million Metrics CorpSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .